MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202617052011 A) filed by Liqsci Biotecnologia Ltda on April 23, 2026, for In Vitro Diagnostic And/Or Prognostic Process For Tumors In Liquid Samples, Kit And In Vitro Clinical Monitoring Process.
Inventors include Reis, Beatriz Da Costa Aguiar Alves; Veiga, Glaucia Raquel Luciano Da; and Fonseca, Fernando Luiz Affonso.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: The present invention pertains to the fields of molecular biology and medicine. More specifically, the present invention discloses a kit and an in vitro diagnostic and/or prognostic process for tumors in liquid biological samples, being particularly useful for the diagnosis and/or prognosis of breast cancer. The process comprises a step of quantifying the genetic expression of HIF1a and comparison with a predetermined level, optionally combined with the expression level and other markers. In one embodiment, dPCR is used for quantification. The present invention provides a novel and improved strategy for tracking cancer, particularly breast cancer, being useful for both clinical work and research.
Disclaimer: Curated by HT Syndication.
